in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
BASF extends offer period for the acquisition of Pronova BioPharma
7:54 AM MST | December 19, 2012 | Sotirios Frantzanas
BASF says it is extending, until 18 January 2013, the offer period for the company's acquisition of all of the issued and outstanding shares of Pronova BioPharma (Lysaker, Norway)—a pioneer in the fields of researching, developing, and manufacturing omega-3 fatty acids—for 12.50 Norwegian krone/share ($2.25), or NK4.84 billion, in cash. The offer remains subject to the terms and conditions set out in the initial voluntary public takeover offer document, published on 5 December 2012. The offer is conditional on BASF...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee